Page 114 - IJB-10-1

International Journal of Bioprinting 3D bioprinting for musculoskeletal system

197. Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers 204. Datta P, Wu Y, Yu Y, Moncal KK, Ozbolat IT. A scaffold
in the diagnosis and monitoring of metabolic bone disease. free 3D bioprinted cartilage model for in vitro toxicology.
Clin Chem. 2017;63:464-474. Methods Mol Biol. 2021;2147:175-183.
doi: 10.1373/clinchem.2016.259085 doi: 10.1007/978-1-0716-0611-7_15
198. Breathwaite E, Weaver J, Odanga J, dela Pena-Ponce M, Lee 205. Ouyang L. Pushing the rheological and mechanical
JB. 3D bioprinted osteogenic tissue models for in vitro drug boundaries of extrusion-based 3D bioprinting. Trends
screening. Molecules. 2020;25:3442. Biotechnol. 2022;40:891-902.
doi: 10.3390/molecules25153442 doi: 10.1016/j.tibtech.2022.01.001
199. Breathwaite EK, Weaver JR, Murchison AC, Treadwell ML, 206. Ouyang L, Armstrong JPK, Lin Y, et al. Expanding and
Odanga JJ, Lee JB. Scaffold-free bioprinted osteogenic and optimizing 3D bioprinting capabilities using complementary
chondrogenic systems to model osteochondral physiology. network bioinks. Sci Adv. 2020;6:eabc5529.
Biomed Mater. 2019;14:065010. doi: 10.1126/sciadv.abc5529
doi: 10.1088/1748-605X/ab4243
207. Chimene D, Peak CW, Gentry JL, et al. Nanoengineered ionic–
200. Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. covalent entanglement (nice) bioinks for 3D bioprinting. ACS
Nat Rev Dis Primers. 2016;2:16072.
doi: 10.1038/nrdp.2016.72 Appl Mater Interfaces. 2018;10:9957-9968.
doi: 10.1021/acsami.7b19808
201. Singh YP, Moses JC, Bandyopadhyay A, Mandal BB. 3D
bioprinted silk-based in vitro osteochondral model for 208. Dubey N, Ferreira JA, Daghrery A, et al. Highly tunable
osteoarthritis therapeutics. Adv Healthc Mater. 2022;11:2200209. bioactive fiber-reinforced hydrogel for guided bone
doi: 10.1002/adhm.202200209 regeneration. Acta Biomater. 2020;113:164-176.
doi: 10.1016/j.actbio.2020.06.011
202. Furrer R, Handschin C. Muscle wasting diseases: Novel
targets and treatments. Annu Rev Pharmacol Toxicol. 209. Shao L, Gao Q, Xie C, Fu J, Xiang M, He Y. Synchronous 3D
2019;59:315-339. bioprinting of large-scale cell-laden constructs with nutrient
doi: 10.1146/annurev-pharmtox-010818-021041 networks. Adv Healthc Mater. 2020;9:e1901142.
doi: 10.1002/adhm.201901142
203. Alave Reyes-Furrer A, De Andrade S, Bachmann D, et
al. Matrigel 3D bioprinting of contractile human skeletal 210. Brassard JA, Nikolaev M, Hübscher T, Hofer M, Lutolf MP.
muscle models recapitulating exercise and pharmacological Recapitulating macro-scale tissue self-organization through
responses. Commun Biol. 2021;4:1183. organoid bioprinting. Nat Mater. 2021;20:22-29.
doi: 10.1038/s42003-021-02691-0 doi: 10.1038/s41563-020-00803-5

Volume 10 Issue 1 (2024) 106 https://doi.org/10.36922/ijb.1037